-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -3.920% | -2.970% | -7.547% | -34.118% | -30.000% | 146.851% | - |
| Vaxart Inc. | -0.710% | -0.639% | -0.356% | -49.821% | -58.457% | -71.193% | -95.333% |
| Larimar Therapeutics Inc. | 3.660% | 8.974% | 18.056% | -40.351% | -8.602% | -5.028% | -81.027% |
News
Trump Approved Nvidia's H200 Exports, but China's Limits Could Change Everything
After months of uncertainty, President Donald Trump announced that the U.S. government would permit Nvidia (NASDAQ: NVDA) to sell its H200 processors to China. Trump announced the decision in a post
Why Intel Is Massively Outperforming Nvidia and AMD This Year
In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC), Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other artificial intelligence (AI) stocks. To learn more,
AMD's CEO Makes an Interesting Prediction About Competitive AI Chips
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other artificial intelligence (AI) stocks. To learn more, check out the short video, consider


